+1 628 258 0071(US) +44
2035 002 764(UK)
Search For Reports
GET FREE SAMPLE R
Home / Reports
/ Breast imaging Market
Please note that the assessment period of report has been updated from 2018-2025 to 2020-2027. Cordially fill the sample
form for updated data
Global Breast Imaging Market is expected to register 7.5% CAGR during the forecast period, 2019 to 2025,
and is expected to reach USD 4.9 billion in 2025.
Breast imaging includes technologies and tools used for screening, detection, and diagnosis of breast cancer. If cancer
is detected, these technologies also help to determine the stage and location of the cancerous cells. The types of breast
cancer are invasive ductal carcinoma, ductal carcinoma in situ, metastatic breast cancer, and inflammatory breast
cancer. Several major manufacturers are involved in research and development for the launch of innovative breast
imaging equipment, which is expected to drive the global market during the forecast period.
However, factors such as stringent regulatory policies, product recall, and others are hampering the growth of
the global market.
The global breast imaging market is segmented based on technology, end users, and region.
The global market for breast imaging, by technology, is segmented into ionizing, non-ionizing, and others. The
ionizing segment is further sub-segmented into mammography, molecular breast imaging (MBI)/molecular
breast-specific gamma imaging (BSGI), PET-CT, contrast enhanced spectral mammography (CESM), and cone
beam computed tomography. The non-ionizing segment is further sub-segmented into breast ultrasound,
breast MRI, breast thermography, optical imaging, and electrical impedance imaging (EIT).
The ionizing segment accounted for the largest segment of the market due to a high number of individuals
opting for mammography. For instance, according to the data collected in the 2016 National Ambulatory
Medical Care Survey (N